Last reviewed · How we verify

NCT05405829: HECGPN

Health Education to Caregivers to Reduce Aspiration Pneumonia

Completed NA Last updated 29 March 2023
What this trial tests

NA trial testing Health education in Oropharyngeal Dysphagia in 178 participants. Completed in 28 March 2023.

Timeline
30 May 2019
Primary endpoint
30 May 2020
28 March 2023

Quick facts

Lead sponsorUniversitat Internacional de Catalunya
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment178
Start date30 May 2019
Primary completion30 May 2020
Estimated completion28 March 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universitat Internacional de Catalunya — full company profile →

Who can join

65 and older, any sex, with Oropharyngeal Dysphagia or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized clinical study with a control group for assessing the decrease in the incidence of pneumonia, in a 12-month follow-up, in older people with cognitive impairment, risk of bronchial aspiration, risk of malnutrition and dependence to perform basic activities of daily living, through the design and implementation of an educational program. to the caregivers of these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Health education

Trials testing the same drug.

Other recruiting trials for Oropharyngeal Dysphagia

Currently open trials in the same condition.

Other Universitat Internacional de Catalunya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05405829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing